In January 2012, Andy was appointed Professor in Environmental Microbiology and in 2016 Distinguished Professor by RMIT University. He started his career as a Research Fellow in Liverpool University, UK and more recently held the position of Reader at the University of Essex, UK. In April 2005, Andy was appointed Chair of Environmental Biotechnology at Flinders University.
He has held a number of key institutional/organisational roles at each university in which he has been employed over the past 30 years. At the University of Essex UK, Andy was Director of the Centre for Environment and Society. At Flinders University, he was appointed Director and Chairman of Flinders Bioremediation. At RMIT University, Andy established, as Director a new University Research Centre, Environment, Sustainability and Remediation and is currently Director of the ARC Training Centre for the Transformation of Australia's Biosolids Resource.
Andy has headed the Environmental Biotechnology Group now at RMIT University (previously based at Essex University and Flinders University) since 1995. Andy has a wealth of research and research and teaching expertise to RMIT University at an International level, particularly in the fields of bioremediation, organic waste treatment, and environmental fate of organic pollutants.
Andy has generated internationally acclaimed research outputs since 1985. He has over 300 peer reviewed publications cited 11,000 times in total, with an annual citation average above 1200 over the past 3 years with an h-index of 54 (Google) and 42 (Scopus). In addition, Andy has published 6 books (3 as author and 3 as editor) and written 42 book chapters. He has currently five provisional patents and one full patent. These metrics demonstrate his respected standing in the research community.
The three main research themes within his research group are:
- Understanding the role of microorganisms in the cycling of nutrients in terrestrial and aquatic environments.
- Studying the impact of anthropogenic activities on microbial activity and diversity in aquatic and terrestrial environments.
- Examining bioenergy production and assessing the suitability of these technologies for commercialisation.
The first 2 areas focus on the influence of pollutants on the activity of the microbial population together with the biodegradation of pollutants in situ. Through collaborations the specific research areas within these two themes vary. Use is made of current technological developments in molecular microbiology environmental chemistry to investigate microbially driven environmental processes.
Andy has successfully completed the supervision of 68 PhD students and 8 Masters by Research students at RMIT University and Flinders and Essex Universities.
Teaching commitments include undergraduate and Masters courses in:
- Environmental Microbiology
- Environmental Biotechnology
- Ph.D. Liverpool University, Department of Genetics and Microbiology, Liverpool, UK, 1986
- B.Sc. (Hons.) Liverpool University, Department of Microbiology, Liverpool, UK, 1983
- Rani, A.,Daniel, V.,Surapaneni, A.,Shahsavari, E.,Haleyur, N.,Mantri, N.,Ball, A. (2021). Evaluation and comparison of recombinase polymerase amplification coupled with lateral-flow bioassay for Escherichia coli O157:H7 detection using different genes In: Scientific Reports, 11, 1 - 12
- De Silva, M.,Ball, A.,Shahsavari, E.,Indrapala, D.,Reichman, S. (2021). The effects of vehicular emissions on the activity and diversity of the roadside soil microbial community In: Environmental Pollution, 277, 1 - 11
- Elliott, J.,Ball, A. (2021). Selection of industrial trade waste resource recovery technologies-A systematic review In: Resources, 10, 1 - 22
- Dike, C.,Shahsavari, E.,Surapaneni, A.,Shah, K.,Ball, A. (2021). Can biochar be an effective and reliable biostimulating agent for the remediation of hydrocarbon-contaminated soils? In: Environment International, 154, 1 - 16
- Hoang, T.,Shahsavari, E.,Bott, N.,Ball, A. (2021). Bioaugmentation of seafood processing wastewater enhances the removal of inorganic nitrogen and chemical oxygen demand In: Aquaculture, 542, 1 - 8
- Hoang, T.,Shahsavari, E.,Bott, N.,Ball, A. (2021). The application of Marinobacter hydrocarbonoclasticus as a bioaugmentation agent for the enhanced treatment of non-sterile fish wastewater In: Journal of Environmental Management, 291, 1 - 8
- Hoang, T.,Shahsavari, E.,Bott, N.,Ball, A. (2021). Application of co-culture technology to enhance protease production by two halophilic bacteria, marinirhabdus sp. And marinobacter hydrocarbonoclasticus In: Molecules, 26, 1 - 10
- Rani, A.,Daniel, V.,Surapaneni, A.,Mantri, N.,Ball, A. (2021). Review: Trends in point-of-care diagnosis for Escherichia coli O157:H7 in food and water In: International Journal of Food Microbiology, 349, 1 - 12
- Gleeson, D.,Martin, B.,Lardner, T.,Ball, A. S., et al, . (2021). Natural attenuation of legacy hydrocarbon spills in pristine soils is feasible despite difficult environmental conditions in the monsoon tropics In: Science of the Total Environment, 799, 1 - 10
- Hoang, T.,Shahsavari, E.,Bott, N.,Ball, A. (2021). Options for Improved Treatment of Saline Wastewater From Fish and Shellfish Processing In: Frontiers in Environmental Science, 9, 1 - 16
13 PhD Current Supervisions17 PhD Completions and 1 Masters by Research Completions
- Circular Economy Accelerator for Transformative Bio-Organics (VHESIF Pool 2) (administered by Deakin University). Funded by: Victorian Higher Education State Investment Fund (VHESIF) - Pool 2 from (2021 to )
- Unravelling soil carbon response to warming in fire-affected ecosystems (ext led by Griffith University). Funded by: ARC Discovery Projects 2021 from (2021 to 2024)
- ARC Training Centre for Transformation of Australia's Biosolids Resource. Funded by: ARC Industrial Transformation Training Centre 2018 onwards from (2020 to 2025)
- Single Particle Elemental Analysis – Imaging Mass Cytometer Facility (administered by University of Melbourne). Funded by: ARC LIEF via other University from (2020 to 2020)
- Inhaled therapeutics for the treatment of childhood Tuberculosis with a next generation nebulisation platform. Funded by: Rebecca Cooper Medical Research Foundation Grant 2017 onwards from (2018 to 2021)